Fluid Sloshing Characteristics in Spacecraft Propellant Tanks with Diaphragms

All spacecraft are launched from the Earth as payloads on a launch vehicle. During portions of the launch profile, the spacecraft could be subjected to nearly purely translational oscillatory lateral motions as the launch vehicle control system guides the rocket along its flight path. All partially-filled liquids tanks, even those with diaphragms, exhibit sloshing behavior under these conditions and some tanks can place large loads on their support structures if the sloshing is in resonance with the control system oscillation frequency. The objectives of this project were to conduct experiments using a full-scale model of a flight tank to 1) determine whether launch vehicle vibrations can cause the diaphragm to achieve a repeatable configuration, regardless of initial condition, and 2) identify the slosh characteristics of the propellant tank under flight-like lateral motions for different diaphragm shapes and vibration levels. The test results show that 1) the diaphragm shape is not affected by launch vibrations, and 2) the resonance-like behavior of the fluid and diaphragm is strongly affected by the nonlinear stiffness and damping provided by the diaphragm

Time Frequency Analysis of Spacecraft Propellant Tank Spinning Slosh

Many spacecraft are designed to spin about an axis along the flight path as a means of stabilizing the attitude of the spacecraft via gyroscopic stiffness. Because of the assembly requirements of the spacecraft and the launch vehicle, these spacecraft often spin about an axis corresponding to a minor moment of inertia. In such a case, any perturbation of the spin axis will cause sloshing motions in the liquid propellant tanks that will eventually dissipate enough kinetic energy to cause the spin axis nutation (wobble) to grow further. This spinning slosh and resultant nutation growth is a primary design problem of spinning spacecraft and one that is not easily solved by analysis or simulation only. Testing remains the surest way to address spacecraft nutation growth. This paper describes a test method and data analysis technique that reveal the resonant frequency and damping behavior of liquid motions in a spinning tank. Slosh resonant frequency and damping characteristics are necessary inputs to any accurate numerical dynamic simulation of the spacecraft

FIELD TESTING OF REMOTE SENSOR GAS LEAK DETECTION SYSTEMS FINAL REPORT

The natural gas pipeline industry routinely checks their pipeline right-of-ways to ensure that leaks are detected. Pipeline companies use various processes to detect signs of leaking pipes, including using vehicles or low-flying aircraft. The leak detection methods range from directly sensing the gas to looking for indirect signs of leakage. The U.S. Department of Energy (DOE) and the U.S. Department of Transportation’s Office of Pipeline Safety (OPS) have provided funding to several commercial companies and research laboratories to develop advanced remote sensor systems to provide high quality, cost-effective leak detection information. To aid in the development and availability of these remote detection systems, the DOE funded a project to conduct field testing of five remote sensor leak detection systems. OPS provided co-funding for this project. The five systems chosen to be included in the field test were being developed by En’Urga Inc., ITT Industries, Inc., LaSen, Inc., Lawrence Livermore National Laboratories, and Physical Sciences Inc. The technologies included passive infrared multi-spectral scanning, laser-based differential absorption LIDAR (Light Detection and Ranging), hyperspectral imaging, and tunable diode laser absorption spectroscopy. The sensor systems were mounted in an unmodified automobile, a helicopter, or a fixed-wing aircraft. A “virtual pipeline,” that simulated conditions of an actual pipeline was created at the Rocky Mountain Oilfield Testing Center field site at NPR-3, north of Casper, Wyoming. The pipeline route was approximately 7.5 miles long and was marked by 14 direction change markers and 22 sets of road crossing markers. Fifteen leak sites, which included three types of gas releases, were established along the route, with natural gas leak rates ranging from 1 scfh to 5,000 scfh. One leak site was designated as a “calibration” site, and the location and leak rate for this site were provided to the equipment providers. Leak sites that were designed to cause plant stress were on continuously from August 30, 2004 through September 17, 2004. The remaining leak sites were set daily during the test week of September 13 to 17, 2004. Four equipment providers were scheduled to collect data along the pipeline path twice each test day. One equipment provider, at their request, was scheduled to collect data once each day for one of their platforms and twice during the entire week for their other platform. Reports of the findings for the individual equipment providers were due to Southwest Research Institute® (SwRI®) within two weeks after the testing period and are included in this report as Appendix I. Based on the data provided, leaks at many of the leak sites were successfully detected. Leak rates of 500 scfh or higher were detected at least 50% of the time. Leak rates of 100 scfh were only detected 15% of the time. Leak rates of 15 scfh and 10 scfh were only detected about 5% of the time. The 1-scfh leak was never detected. There were also a large number of “false positive” leak sites identified by the equipment providers. Some of the equipment providers made system improvements during the week including repairing malfunctioning equipment, mechanical modifications to improve performance in field applications, and developing improved data handling schemes. Other modifications have been defined for future work by some of the equipment providers. Improvements for potential future testing efforts have been identified and include improving the pipeline route and adding more leak sites

Food, Nutrition and Agrobiodiversity Under Global Climate Change

Available evidence and predictions suggest overall negative effects on agricultural production as a result of climate change, especially when more food is required by a growing population. Information on the effects of global warming on pests and pathogens affecting agricultural crops is limited, though crop–pest models could offer means to predict changes in pest dynamics, and help design sound plant health management practices. Host-plant resistance should continue to receive high priority as global warming may favor emergence of new pest epidemics. There is increased risk, due to climate change, to food and feed contaminated by mycotoxin-producing fungi. Mycotoxin biosynthesis gene-specific microarray is being used to identify food-born fungi and associated mycotoxins, and investigate the influence of environmental parameters and their interactions for control of mycotoxin in food crops. Some crop wild relatives are threatened plant species and efforts should be made for their in situ conservation to ensure evolution of new variants, which may contribute to addressing new challenges to agricultural production. There should be more emphasis on germplasm enhancement to develop intermediate products with specific characteristics to support plant breeding. Abiotic stress response is routinely dissected to component physiological traits. Use of transgene(s) has led to the development of transgenic events, which could provide enhanced adaptation to abiotic stresses that are exacerbated by climate change. Global warming is also associated with declining nutritional quality of food crops. Micronutrient-dense cultivars have been released in selected areas of the developing world, while various nutritionally enhanced lines are in the release pipeline. The high-throughput phenomic platforms are allowing researchers to accurately measure plant growth and development, analyze nutritional traits, and assess response to stresses on large sets of individuals. Analogs for tomorrow’s agriculture offer a virtual natural laboratory to innovate and test technological options to develop climate resilience production systems. Increased use of agrobiodiversity is crucial to coping with adverse impacts of global warming on food and feed production and quality. No one solution will suffice to adapt to climate change and its variability. Suits of technological innovations, including climate-resilient crop cultivars, will be needed to feed 9 billion people who will be living in the Earth by the middle of the twenty-first century

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats.

The enzyme dipeptidyl peptidase-IV (DPP-4) inactivates the incretin hormone glucagon-like peptide-1 (GLP-1). Because GLP-1 has therapeutic effects in patients with type 2 diabetes, but its potential is limited by a short half-life, DPP-4 inhibition is a promising approach to diabetes treatment. This study examined acute (single dose) and chronic (once-a-day dosing for 21 days) effects of the DPP-4 inhibitor vildagliptin (0.03-10 mg/kg) on plasma DPP-4 activity, intact GLP-1, glucose, and insulin after an oral glucose load in insulin-resistant Zucker fatty rats and acute effects in mildly insulin-resistant high-fat-fed normal rats. A single oral dose of vildagliptin in Zucker rats produced a rapid and dose-related inhibition of DPP-4: the minimum effective dose (MED) was 0.3 mg/kg. Glucose-induced increases of intact GLP-1 were greatly but similarly enhanced by vildagliptin at doses > or =0.3 mg/kg. Postload glucose excursions decreased, and the insulinogenic index (Deltainsulin/Deltaglucose at 10 min) increased, with an MED of 0.3 mg/kg and a maximally effective dose of 3 mg/kg. The effects of vildagliptin after chronic treatment were nearly identical to those of acute administration, and vildagliptin had no effect on body weight. In fat-fed normal rats, vildagliptin (3 mg/kg) also decreased postload glucose excursions and increased the insulinogenic index, but these effects were smaller than those in Zucker rats. Thus, vildagliptin is an orally effective incretin enhancer with antihyperglycemic activity in insulin-resistant rats and exhibits no tachyphylaxis. GLP-1-mediated augmentation of glucose-induced insulin release seems to make the major contribution to the antidiabetic properties of vildagliptin